Filing Flows › Indivior Pharmaceuticals (INDV) › Net income
Indivior Pharmaceuticals (INDV) net income by quarter
Indivior Pharmaceuticals' net income was $137M in Q3 2026 (third quarter 2026), +12% from Q2 2026. Over the last 7 quarters it ranged from $18.0M (Q2 2025) to $137M (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $137M | +12% | +226% |
| Q2 2026 | $122M | +37% | +578% |
| Q1 2026 | $89.0M | -13% | +89% |
| Q4 2025 | $102M | +143% | — |
| Q3 2025 | $42.0M | +133% | — |
| Q2 2025 | $18.0M | -62% | — |
| Q1 2025 | $47.0M | — | — |
Q3 2026 at a glance
Indivior Pharmaceuticals, Q3 2026: revenue $356M (+13% year over year), operating margin 50.6%, net earnings $137M, operating cash flow $97.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Indivior Pharmaceuticals' net income?
Indivior Pharmaceuticals' net income was $137M in Q3 2026 (third quarter 2026), +12% from Q2 2026.
How has Indivior Pharmaceuticals' net income changed?
Over the last 7 quarters it ranged from $18.0M (Q2 2025) to $137M (Q3 2026).
Q3 2026 results → · How Indivior Pharmaceuticals makes money →